ACURX PHARMACEUTICALS INC (ACXP) Stock Income Statement
NASDAQ:ACXP - Nasdaq - US00510M1045 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 16.44M | 14.58M | 12.09M | 12.82M | 4.60M | |||
| Research and Development | 6.52M | 6.04M | 4.75M | 2.03M | 2.20M | |||
| Selling, General, and Administrative Expenses | 9.91M | 8.53M | 7.34M | 10.78M | 2.40M | |||
| Operating Income | -16.44M | -14.58M | -12.09M | -12.82M | -4.60M | |||
| Non Recurring Items | N/A | N/A | 0.00 | 70.00K | N/A | |||
| Income Before Taxes | -16.44M | -14.58M | -12.09M | -12.75M | -4.60M | |||
| Net Income | -16.44M | -14.58M | -12.09M | -12.75M | -4.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.09 | -1.15 | -1.12 | -1.49 | -0.48 | |||
| Non GAAP EPS | -1.08 | -1.14 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD